Jeff Jonas, MD

Jeff is a Partner at Cure Ventures and a member of the board of directors of Sage Therapeutics. He has more than two decades of experience on both the scientific and business sides of the pharmaceutical and healthcare industries, particularly in the CNS field. Previously, Jeff held positions as the chief innovation officer and, earlier, the chief executive officer and president of Sage. He currently serves on the board of directors of Karuna Pharmaceuticals and as the non-executive chair of the board of directors at Noema Pharma AG. He has published more than 70 scientific papers and chapters; authored more than 100 books, scientific articles, and abstracts; and has received numerous awards. Jeff received his Bachelor of Arts from Amherst College and MD from Harvard Medical School. He completed a residency in psychiatry at Harvard and then served as the chief resident in psychopharmacology at McLean Hospital, Harvard Medical School.